As regards cerebrovascular disease, a meta‐analysis reported a relationship between CYP2C19 poor metaboliser alleles and efficacy of clopidogrel in secondary prevention of stroke/TIA.80 The gene discussed is CYP2C19; the disease is cerebrovascular disorder.